Perspectives on Outsourcing

BioPharm International: Feb 01, 2015
Market forces may limit the success of CMOs.
BioPharm International: Jan 01, 2015
There are significant differences between small molecules and biologics fill/finish capacity.
BioPharm International: Dec 01, 2014
Outsourcing is taking on a greater role in the biopharmaceutical manufacturing industry.
BioPharm International: Oct 31, 2014
European CDMOs want into the US market, but entry options are limited.
BioPharm International: Sep 30, 2014
The trend of exits from the CMO industry looks to be gaining momentum.
BioPharm International: Aug 31, 2014
Annual study shows geographic proximity not a factor in CMO selection.
BioPharm International: May 31, 2014
With budgets growing, clients see CMOs' costs as less crucial.
BioPharm International: Apr 30, 2014
The CMO industry's value proposition is limiting its market penetration.
BioPharm International: Mar 31, 2014
Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.
BioPharm International: Mar 01, 2014
Changes in company ownership shake up the CMO industry.